share_log
Breakings ·  Dec 24, 2024 16:11

Abbott Laboratories announced that it has reached an agreement with the Medical Devices company DexCom to resolve all patent disputes between the two parties regarding continuous glucose monitoring devices.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment